SGA

Sector Gamma AS Portfolio holdings

AUM $306M
This Quarter Return
-8.84%
1 Year Return
+4.68%
3 Year Return
+19.67%
5 Year Return
+46.47%
10 Year Return
+161.43%
AUM
$391M
AUM Growth
+$391M
Cap. Flow
-$13.7M
Cap. Flow %
-3.51%
Top 10 Hldgs %
65.45%
Holding
31
New
2
Increased
13
Reduced
13
Closed
3

Top Buys

1
GMED icon
Globus Medical
GMED
$11M
2
BMY icon
Bristol-Myers Squibb
BMY
$9.53M
3
GEHC icon
GE HealthCare
GEHC
$5.32M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
$4.41M
5
ELV icon
Elevance Health
ELV
$4.27M

Top Sells

1
NUVA
NuVasive, Inc.
NUVA
$11.1M
2
BAX icon
Baxter International
BAX
$10.6M
3
CAH icon
Cardinal Health
CAH
$10.5M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
$5.89M
5
BDX icon
Becton Dickinson
BDX
$5.44M

Sector Composition

1 Healthcare 99.26%
2 Consumer Staples 0.74%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
GILD icon
1
Gilead Sciences
GILD
$140B
$46.7M 11.93%
623,123
+21,756
+4% +$1.63M
BMY icon
2
Bristol-Myers Squibb
BMY
$96B
$39M 9.97%
671,780
+164,204
+32% +$9.53M
BIIB icon
3
Biogen
BIIB
$19.4B
$26.8M 6.85%
104,286
+8,529
+9% +$2.19M
MDT icon
4
Medtronic
MDT
$119B
$25.7M 6.57%
327,903
-18,605
-5% -$1.46M
INCY icon
5
Incyte
INCY
$16.5B
$25M 6.39%
432,545
+35,013
+9% +$2.02M
CAH icon
6
Cardinal Health
CAH
$35.5B
$22.9M 5.86%
264,136
-120,506
-31% -$10.5M
BDX icon
7
Becton Dickinson
BDX
$55.3B
$18.6M 4.75%
71,884
-21,039
-23% -$5.44M
ELV icon
8
Elevance Health
ELV
$71.8B
$17.9M 4.58%
41,147
+9,796
+31% +$4.27M
ZBH icon
9
Zimmer Biomet
ZBH
$21B
$17.9M 4.56%
159,069
+10,257
+7% +$1.15M
GEHC icon
10
GE HealthCare
GEHC
$33.7B
$15.6M 3.99%
229,589
+78,261
+52% +$5.32M
CNC icon
11
Centene
CNC
$14.3B
$15.4M 3.93%
223,148
-21,801
-9% -$1.5M
EW icon
12
Edwards Lifesciences
EW
$47.8B
$14.8M 3.77%
212,995
+17,704
+9% +$1.23M
LH icon
13
Labcorp
LH
$23.1B
$13M 3.33%
64,857
-8,247
-11% -$1.66M
GMED icon
14
Globus Medical
GMED
$8.27B
$11M 2.81%
+221,827
New +$11M
THC icon
15
Tenet Healthcare
THC
$16.3B
$10.4M 2.66%
157,975
-3,482
-2% -$229K
CTLT
16
DELISTED
CATALENT, INC.
CTLT
$9.43M 2.41%
207,129
+27,041
+15% +$1.23M
ALNY icon
17
Alnylam Pharmaceuticals
ALNY
$58.5B
$9.38M 2.4%
52,968
+24,901
+89% +$4.41M
BMRN icon
18
BioMarin Pharmaceuticals
BMRN
$11.2B
$8.5M 2.17%
96,048
-66,620
-41% -$5.89M
IONS icon
19
Ionis Pharmaceuticals
IONS
$6.79B
$7.51M 1.92%
165,616
+5,215
+3% +$237K
BAX icon
20
Baxter International
BAX
$12.7B
$7.29M 1.86%
193,243
-280,391
-59% -$10.6M
BRKR icon
21
Bruker
BRKR
$5.16B
$6.44M 1.65%
103,355
-8,887
-8% -$554K
RARE icon
22
Ultragenyx Pharmaceutical
RARE
$2.89B
$4.11M 1.05%
115,166
+14,561
+14% +$519K
QGEN icon
23
Qiagen
QGEN
$10.1B
$4.08M 1.04%
100,713
-26,813
-21% -$1.09M
ACAD icon
24
Acadia Pharmaceuticals
ACAD
$4.38B
$3.75M 0.96%
179,785
-20,911
-10% -$436K
LNTH icon
25
Lantheus
LNTH
$3.73B
$3.54M 0.91%
50,962
+653
+1% +$45.4K
1
2